Lanean...
Outcome of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in real-life setting
AIMS: To evaluate outcome of anti-vascular endothelial growth factor (VEGF) therapy for the treatment of neovascular age-related macular degeneration (nAMD) in the real-life setting and to compare incidence of ocular serious adverse events (SAE) after injections administered by nurses and physicians...
Gorde:
| Argitaratua izan da: | Br J Ophthalmol |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047152/ https://ncbi.nlm.nih.gov/pubmed/29074495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-311055 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|